Publication | Closed Access
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
17
Citations
0
References
2016
Year
Metabolic DisorderPathologyPharmacotherapyFatty Liver DiseaseObesityMetabolic SyndromeMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisHealth SciencesDiabetes ManagementLiver PhysiologyInsulin ManagementType 2Long-term Pioglitazone TreatmentPharmacologyHepatologyDiabetesLiver DiseaseDiabetes MellitusMedicineMetabolic Defects
Nonalcoholic steatohepatitis (NASH) is a common chronic liver condition affecting obese patients with prediabetes or type 2 diabetes mellitus (T2DM). Pioglitazone seems to target metabolic defects,...